A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)
Clinical trial NCT02045732 · TERMINATED
Trial details
- NCT number
- NCT02045732
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-10-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.